Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suhail Ali

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Predicting response to herceptin therapyAllan Lipton, Kim Leitzel, Suhail Ali
Current Osteoporosis Reports|January 11, 2015
Antiresorptive therapy in the management of cancer treatment-induced bone lossAshwani Garg, Kim Leitzel, Suhail Ali, et al.
Advances in Experimental Medicine and Biology|January 5, 2013
Impact of genetic targets on prostate cancer therapyHassan Sheikh, Junaid Abdulghani, Suhail Ali, et al.
Journal of Clinical Gastroenterology|March 11, 2010
Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancerAllan Lipton, Cynthia Campbell-Baird, Lois Witters, et al.
Breast Cancer Research : BCR|June 15, 2007
HER-2/neu diagnostics in breast cancerWalter P Carney, Kim Leitzel, Suhail Ali, et al.
The Journal of Prosthetic Dentistry|August 26, 2009
The in vitro effect of different implant angulations and cyclic dislodgement on the retentive properties of an overdenture attachment systemSuhail Ali Al-Ghafli, Konstantinos X Michalakis, Hiroshi Hirayama, et al.
Medicine|January 20, 2025
Functional neurological disorder treated with psychoeducation: A case reportAmal Yousef Alhazmi, Ahmed Ahmed Attar, Suhail Ali Labban, et al.
Clinical Chemistry|September 23, 2003
Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancerWalter P Carney, Rainer Neumann, Allan Lipton, et al.
Clinical Breast Cancer|July 13, 2004
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancerWalter P Carney, Rainer Neumann, Allan Lipton, et al.
Human Vaccines|July 10, 2007
A multicenter, prospective, open-label, non-comparative study to evaluate the immunogenicity and tolerance of a new, fully liquid pentavalent vaccine (DTwP-HepB-Hib vaccine)S Suhail Ali, Sudha Rao Chandrashekar, Meenu Singh, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Predicting response to herceptin therapyAllan Lipton, Kim Leitzel, Suhail Ali
Current Osteoporosis Reports|January 11, 2015
Antiresorptive therapy in the management of cancer treatment-induced bone lossAshwani Garg, Kim Leitzel, Suhail Ali, et al.
Advances in Experimental Medicine and Biology|January 5, 2013
Impact of genetic targets on prostate cancer therapyHassan Sheikh, Junaid Abdulghani, Suhail Ali, et al.
Journal of Clinical Gastroenterology|March 11, 2010
Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancerAllan Lipton, Cynthia Campbell-Baird, Lois Witters, et al.
Breast Cancer Research : BCR|June 15, 2007
HER-2/neu diagnostics in breast cancerWalter P Carney, Kim Leitzel, Suhail Ali, et al.
The Journal of Prosthetic Dentistry|August 26, 2009
The in vitro effect of different implant angulations and cyclic dislodgement on the retentive properties of an overdenture attachment systemSuhail Ali Al-Ghafli, Konstantinos X Michalakis, Hiroshi Hirayama, et al.
Medicine|January 20, 2025
Functional neurological disorder treated with psychoeducation: A case reportAmal Yousef Alhazmi, Ahmed Ahmed Attar, Suhail Ali Labban, et al.
Clinical Chemistry|September 23, 2003
Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancerWalter P Carney, Rainer Neumann, Allan Lipton, et al.
Clinical Breast Cancer|July 13, 2004
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancerWalter P Carney, Rainer Neumann, Allan Lipton, et al.
Human Vaccines|July 10, 2007
A multicenter, prospective, open-label, non-comparative study to evaluate the immunogenicity and tolerance of a new, fully liquid pentavalent vaccine (DTwP-HepB-Hib vaccine)S Suhail Ali, Sudha Rao Chandrashekar, Meenu Singh, et al.
Pageof 2